American College of Cardiology Annual Meeting

Conference Coverage

Research Summaries

Conference Coverage

Conference Coverage

AI Echocardiography Model Shows High Negative Predictive Value for Detecting ATTR-CM in Diverse Heart Failure Cohort

03/21/2015

Kate Young

A prospective analysis presented at the 2026 American College of Cardiology’s Annual Scientific Session evaluated whether an artificial intelligence model applied to routine echocardiography could help...

03/21/2015

Research Summaries

Conference Coverage

Conference Coverage

Catheter Ablation Associated With Lower Mortality, Stroke Risk in Cardiac Amyloidosis Patients With Atrial Fibrillation

04/13/2026

Kate Young

A large real-world cohort analysis presented at the American College of Cardiology’s Annual Scientific Session suggests catheter ablation may be associated with improved survival and reduced stroke risk...

04/13/2026

Research Summary

Research Summary

Tafamidis Reduces Mortality in Octogenarian Patients With ATTR-CM: ACC.26 Analysis

04/09/2026

Ashton L. Stahl

A systematic review and meta-analysis presented at the 2026 American College of Cardiology Scientific Session evaluated whether tafamidis was associated with improved survival in patients aged 80 years and...

04/09/2026

Conference Coverage

Conference Coverage

Tafamidis-Associated Functional Stability Predicts Lower Mortality in ATTR-CM, Post-Hoc Analysis Finds

03/29/2026

Anthony Calabro, MA

A post-hoc analysis presented at the American College of Cariology’s Annual Scientific Session suggests that maintaining functional stability, measured by 6-minute walk distance, is associated with lower...

03/29/2026

Conference Coverage

Conference Coverage

RNA Therapeutics Improve Survival, Reduce Cardiac Failure in Transthyretin Amyloidosis

03/28/2026

Anthony Calabro, MA

A meta-analysis of randomized controlled trials presented at the American College of Cardiology’s Annual Scientific Session suggests RNA therapeutics reduce mortality and cardiac failure risk in...

03/28/2026

Conference Coverage

Conference Coverage

Vutrisiran Improves Quality of Life Measures in ATTR-CM: HELIOS-B Analysis from ACC.26

03/19/2026

Ashton L. Stahl

A prespecified analysis of the HELIOS-B trial evaluates how vutrisiran affects individual components of quality of life in transthyretin cardiomyopathy, offering clinically relevant insights for cardiology...

03/19/2026

April 2026

Current Issue

April 2026